CCND3 might be associated with the prognosis in patients with cervical squamous cell cancer or liver hepatocellular cancer or sarcoma or thymoma or thyroid carcinoma or uterine corpus endometrial carcinoma (Figure 2A‐T) (P < 0.05). Here, CCND3 is linked to thyroid gland carcinoma.